[1] Liang P,Zu J,Yin J, et al. The independent impact of newborn hepatitis B vaccination on reducing HBV prevalence in China, 1992-2006: A mathematical model analysis. J Theor Biol, 2015, 386: 115-121. [2] 中华医学会感染病学分会,中华医学会肝病学分会.慢性乙型肝炎临床治愈(功能性治愈)专家共识.中华肝脏病杂志,2019,27:594-603. [3] 李汨,聂青,韩曼, 等.HBV相关肝细胞癌的危险因素、早期筛查和预防策略.临床肝胆病杂志,2019,35:651-655. [4] 卢君瑶,王登宇,尹东林, 等.HBV相关肝细胞癌的临床特征及危险因素分析.肝脏,2020,25:285-287. [5] Tseng TC,Liu CJ,Yang HC,et al. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads. .Hepatology, 2013, 57: 441-450. [6] 夏国美,李旭,叶琚,等.慢性 HBV 感染者血清 HBsAg 定量水平 HBV DNA 与肝脏组织病理学分析 . 安徽医学, 2013,34: 1752-1755. [7] 李强,黄玉仙,陈良.ALT正常的HBeAg阳性高病毒载量慢性HBV感染者明显肝组织学改变的独立预测因素.临床肝胆病杂志,2016,32:1310-1314. [8] Gui HL,Wang H,Yang YH, et al. Significant histopathology in Chinese chronic hepatitis B patients with persistently high-normal alanine aminotransferase. J Viral Hepat, 2010, null: 44-50. [9] Cheng JL,Wang XL,Yang SG,et al.Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase chronic hepatitis B patients.World J Gastroenterol,2017,23:2802-2810. [10] Zhang ZQ,Lu W,Wang YB,et al. Measurement of the hepatitis B core-related antigen is valuable for predicting the pathological status of liver tissues in chronic hepatitis B patients. J Virol Methods, 2016, 235: 92-98. [11] 辛菊梅.慢性乙型肝炎及肝硬化患者HBsAg和HBV DNA定量检测的临床意义.临床输血与检验,2020,22:203-205. [12] 韦新焕,张晶,张卫, 等.非活动性HBsAg携带者临床特征及自发性HBsAg血清学清除相关因素分析.肝脏,2020,25:128-130,154. [13] Xiang X,You XM,Zhong JH,et al. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection. J Hepatol, 2017, 67: 885-886. [14] Tan YW,Ye Y,Zhou XB,et al. Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferase. PLoS ONE, 2015, 10: e0123452. [15] 朱晓红,陈智娴,庄勋, 等.不同干预措施预防乙型肝炎病毒母婴传播的网络Meta分析.中华实验和临床感染病杂志(电子版),2018,12:316-323. |